Showing results (101-110 of 138) with videos related to
Sort By:
Pageof 14
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 7, 2010
Improved strut coverage and less late incomplete apposition with thin-strut TAXUS Liberté vs. TAXUS Express: the importance of stent platform design for drug-eluting stentsNeil J Weissman, Mark A Turco, John A Ormiston, et al.JACC. Cardiovascular Interventions|May 26, 2009
Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from the TAXUS ATLAS programMark A Turco, John A Ormiston, Jeffrey J Popma, et al.Circulation. Cardiovascular Interventions|April 10, 2015
Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized TrialDean J Kereiakes, Ian T Meredith, Stephan Windecker, et al.The New England Journal of Medicine|February 14, 2007
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stentsGregg W Stone, Jeffrey W Moses, Stephen G Ellis, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 15, 2016
Safety and efficacy of a bioabsorbable polymer-coated, everolimus-eluting coronary stent in patients with diabetes: the EVOLVE II diabetes substudyDean J Kereiakes, Ian T Meredith, Monica Masotti, et al.Journal of the American College of Cardiology|October 22, 2013
Short-term and long-term clinical impact of stent thrombosis and graft occlusion in the SYNTAX trial at 5 years: Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery trialVasim Farooq, Patrick W Serruys, Yaojun Zhang, et al.European Heart Journal|May 23, 2014
Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trialStuart J Head, Piroze M Davierwala, Patrick W Serruys, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 9, 2009
Three-year follow-up of the ARTS-II# - sirolimus-eluting stents for the treatment of patients with multivessel coronary artery diseasePatrick W Serruys, Joost Daemen, Marie-Claude Morice, et al.Journal of the American College of Cardiology|May 25, 2010
Clinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System) trialDean J Kereiakes, Louis A Cannon, Robert L Feldman, et al.Circulation|June 15, 2013
Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX scoreVasim Farooq, Patrick W Serruys, Christos V Bourantas, et al.Pageof 14